Takeda Pharmaceutical Co Ltd
TSE:4502
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Takeda Pharmaceutical Co Ltd
TSE:4502
|
JP |
|
F
|
Fiskars Oyj Abp
F:A8X
|
FI |
|
M
|
MDU Resources Group Inc
F:MRE
|
US |
|
Brookfield Infrastructure Partners LP
NYSE:BIP
|
BM |
|
AST SpaceMobile Inc
NASDAQ:ASTS
|
US |
|
A
|
APA Corp (US)
BMV:APA
|
US |
|
L
|
Loews Corp
F:LTR
|
US |
|
B
|
Brunello Cucinelli SpA
OTC:BCUCY
|
IT |
|
Saab AB
F:SDV1
|
SE |
|
T
|
Telenet Group Holding NV
F:T4I
|
BE |
|
S
|
Standard Motor Products Inc
XBER:SRU
|
US |
|
H
|
HALEON PLC
XMUN:H6D
|
UK |
|
Z
|
Zalando SE
XHAM:ZAL
|
DE |
|
C
|
Concord Biotech Ltd
NSE:CONCORDBIO
|
IN |
Wall St Price Targets
Price Targets Summary
Takeda Pharmaceutical Co Ltd
According to Wall Street analysts, the average 1-year price target for Takeda Pharmaceutical Co Ltd is 6 316.39 JPY with a low forecast of 5 252 JPY and a high forecast of 8 295 JPY.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is Takeda Pharmaceutical Co Ltd's stock price target?
Price Target
6 316.39
JPY
According to Wall Street analysts, the average 1-year price target for Takeda Pharmaceutical Co Ltd is 6 316.39 JPY with a low forecast of 5 252 JPY and a high forecast of 8 295 JPY.
What is the Revenue forecast for Takeda Pharmaceutical Co Ltd?
Projected CAGR
3%
Over the last 14 years, the compound annual growth rate for Revenue has been 8%. The projected CAGR for the next 3 years is 3%.
What is the Gross Profit forecast for Takeda Pharmaceutical Co Ltd?
Projected CAGR
2%
Over the last 14 years, the compound annual growth rate for Gross Profit has been 7%. The projected CAGR for the next 2 years is 2%.
What is the Operating Income forecast for Takeda Pharmaceutical Co Ltd?
Projected CAGR
-24%
Over the last 14 years, the compound annual growth rate for Operating Income has been 7%. The projected CAGR for the next 1 year is -24%.
